SCHEMBL29856498

SCHEMBL29856498

Nc1ncccc1C#CC1CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
GRM5 P41594 1/20 0.44
PTPN11 Q06124 1/20 0.41
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
NAPRT Q6XQN6 1/20 0.34
CSF1R P07333 1/20 0.33
PIK3CD O00329 3/20 0.32
PIK3CA P42336 3/20 0.32
PIK3CB P42338 3/20 0.32
PIK3CG P48736 3/20 0.32
KDM4E B2RXH2 2/20 0.32
RECQL P46063 1/20 0.32
MAP4K4 O95819 1/20 0.32
ELANE P08246 1/20 0.31
PDK2 Q15119 1/20 0.31
KCNH2 Q12809 1/20 0.31
LTA4H P09960 1/20 0.31
MAPK14 Q16539 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31690840 1.00 CYP1A2 (0.44) CYP1A2GRM5PTPN11NOS3NOS1
SCHEMBL31690851 0.93 GRM5 (0.53) CYP1A2GRM5PTPN11NOS3NOS1
SCHEMBL2592722 0.92 CYP1A2 (0.39) CYP1A2GRM5PTPN11NOS3NOS1
SCHEMBL14740065 0.92 CYP1A2 (0.39) CYP1A2GRM5PTPN11NOS3NOS1
SCHEMBL31690836 0.92 GRM5 (0.55) CYP1A2GRM5PTPN11NOS3NOS1
SCHEMBL30942701 0.89 CYP1A2 (0.39) CYP1A2GRM5PTPN11NOS3NOS1
SCHEMBL23858285 0.82 PIK3CD (0.38) CYP1A2GRM5NAPRTPIK3CDPIK3CA
SCHEMBL15730262 0.79 CYP1A2 (0.47) CYP1A2GRM5PTPN11KCNH2PGK1
SCHEMBL18188415 0.79 GRM5 (0.44) CYP1A2GRM5PTPN11PDK2KCNH2
SCHEMBL15723883 0.76 CYP1A2 (0.41) CYP1A2GRM5PTPN11PIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022169974-A1 INHIBITORS OF URAT1 AND PHARMACEUTICAL USES THEREOF NEXYS THERAPEUTICS, INC. (US) 2022-08-11 WO disclosed